The largest database of trusted experimental protocols

9 protocols using human fc blocking reagent

1

Quantifying T-cell activation and proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
After four days of co-culture, the cells were harvested and flow cytometry was performed, which consisted of washing the cells with physiological saline solution (PSS), blocking the cells with Fc Blocking Reagent Human (Miltenyi Biotec, Bergisch Gladbach, Germany), resuspending the cells in 100 μL of PBS containing 1 mM EDTA and 3% FBS and incubating the cells at 4 °C with antibodies (CD3, CD4, and CD8 conjugated to PE (BD Biosciences, Franklin Lakes, NJ, USA) for 20 min; then, the cells were washed with 1 mL of cytometry buffer (PBS containing 1 mM EDTA and 3% FBS). The cells were analyzed in a FACS Canto II Flow Cytometer (BD Biosciences), where 10,000 events were captured per sample. The data were analyzed with FlowJo 10 software (Ashland, OR, USA), and the average fluorescence intensities were normalized using 1 as the control for each experiment. CD3+ T-cells activated in the absence of MSCs were used as the positive control and were considered as 100% proliferation. The proliferation levels observed in co-cultures were normalized to this control. FlowJo 10 software was used for the analysis.
+ Open protocol
+ Expand
2

Taste Receptor Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Caffeine (Sigma Aldrich, St. Louis, MO, USA) was dissolved in distilled water, Gemcitabine (Eli Lilly & Co., Indianapolis, IN, USA) in phosphate buffered saline (PBS; Sigma Aldrich), and 5-Fluorouracil (5-FU; Sigma Aldrich) in Dimethylsulfoxide (DMSO; Sigma Aldrich). For Western blot analysis the following antibodies were used: anti-ABCG2 (EPR2099, abcam); anti-Phospho-Akt Ser473 (D9E, Cell Signaling, Cambridge, UK), anti-pan-Akt (C67E7, Cell Signaling); anti-GAPDH (14C10, Cell signaling); anti-T2R10 (orb 164582; Biorbyt, Cambridge, UK); anti-tubulin (sc-58886, Santa Cruz); goat anti-rabbit IgG-horse radish peroxidase (HRP; Santa Cruz) as secondary antibody. For flow cytometry, a Fc Blocking Reagent (human, Miltenyi Biotec, Bergisch-Gladbach, Germany) was used; anti-T2R10 (ab138285, abcam, Cambridge, UK), a rabbit polyclonal isotype control (abcam), and anti-rabbit-IgG conjugated with phycoerythrin (PE) (Jackson Immunoresearch, West Grove, PA, USA).
+ Open protocol
+ Expand
3

Quantifying CD80 Expression in LPS-treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We harvested the cells 24 hours after LPS administration. The cells were stained with an FITC-anti-human CD80 antibody (BioLegend, San Diego, California, USA) or FITC mouse IgG1, k isotype (Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA) for 30 minutes at 4°C after blocking the nonspecific Fc receptor using FC blocking reagent human (Miltenyi Biotec) for 10 minutes. After staining, the cells were washed immediately and resuspended in AutoMACS Runnig Buffer. Fluorescence data were collected using an Attune NxT Flow Cytometer, and the FITC-positive cell population was evaluated using an excitation wavelength of 488 nm. The flow cytometry files were analyzed using FlowJo software (Becton, Dickinson and Company).
+ Open protocol
+ Expand
4

Multiparameter PBMC Immunophenotyping for scRNAseq

Check if the same lab product or an alternative is used in the 5 most similar protocols
For isolation of cells for scRNAseq, freshly isolated PBMC were FC block- treated (2 ul FC blocking reagent human (Miltenyi Biotech) and 48 ul staining buffer (1% BSA in PBS, filtered through a 40 um filter)/1x106 cells) and incubated 10’ on ice. Cells were washed and stained in 50 ul final/1x106 cells of antibody cocktail (CD3-APC (HIT3α, BD), CD19-APC (SJ25C1, BD), CD14-PE-Cy7 (M5E2, BD), CD56-PE-Cy7 (B159, BD), HLA-DR-APC-H7 (B159, BD), CD11c-AF700 (3.9, eBioscience), CD123-BV650 (6H6, Biolegends), CD16-BV605 (3G8, Biolegends)). Life- dead staining with 7AAD (BD) was done shortly before sorting on a FACS (ARIAII, BD) with the 100 uM nozzle using gating strategy shown in Supplemental Figure 1. For isolation of cells for qPCR, the same panel was used including also EMP1-FITC (Biozol) (Supplemental Figure 4A).
+ Open protocol
+ Expand
5

Isolation and Immunophenotyping of Murine Myeloid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood (100 μl) from the retro-orbital sinus was collected into EDTA blood collection tubes (BD Biosciences San Jose, CA). Blood samples were mixed with 250 μl of 2% dextran (Sigma-Aldrich, St. Louis, MO) and incubated at 37°C for 30 min to sediment red blood cells. Mononuclear cells in the supernatant were transferred and centrifuged at 400g. Contaminating red blood cells were removed by the addition of Ammonium-Chloride-Potassium (ACK) red blood cell lysis buffer (Lonza, Alpharetta, GA). Samples were then blocked with 5% mouse Fc blocking reagent (2.4G2; BD Biosciences) and 5% human Fc blocking reagent (Miltenyi Biotec, Auburn, GA) in fluorescence-activated cell sorting (FACS) buffer [1% FBS and 1 mM EDTA in phosphate-buffered saline (PBS)] before antibody staining. Blocked cells were stained with antibodies against hCD8-allophycocyanin (APC; SK1), mLy-6C-phycoerythrin (PE; AL-21), mLy-6G-Fluorescein isothiocyanate (FITC; 1A8), mF4/80-PE-Cy7 (BM8), hCD4-APC/Cyanine7 (APC-Cy7; SK3), and hCD20–Violet 421 (2H7) at 4°C for 30 min. Labeled cells were washed and fixed in 1% paraformaldehyde (PFA).
+ Open protocol
+ Expand
6

Surface Marker Analysis of CD14+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface immunostainings were performed at day 6 post-isolation of the CD14 + cells from PBMCs. After a 15 min-incubation step with human Fc blocking reagent (MACS Miltenyi Biotec), cell surface markers were detected by a 30 min-incubation at 4 °C with 4 µg/mL Pacific Blue-conjugated mouse anti-CD14 (clone 63D3, Biolegend), a 1:20 dilution of APC-conjugated mouse anti-CD163 (clone REA812, MACS Miltenyi Biotec), 0.14 µg/mL PE-conjugated mouse anti-HLA-DR (clone LN3, Invitrogen) and a 1:20 dilution of PE-Cy7-conjugated mouse anti-CD11b (clone ICRF44, BD Biosciences), diluted in staining buffer (PBS - 1% FBS). Flow cytometric analysis was performed using a BD FACS Canto II and the data were analyzed with Flow Jo software (Tree Star).
+ Open protocol
+ Expand
7

Intracellular Cytokine Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate intracellular cytokine production, 1 x 106 PBMCs or BACs were stimulated with Phorbol-12-Myristate-13-Acetate (PMA, 25 ng/ml, Sigma Chemical, St. Louis, MO) plus ionomycin (1μM, Sigma Chemical) in the presence of brefeldin A (5 μg/ml, Sigma Chemical) for 4 h at 37°C and in 5% CO2. After activation, the cells were washed with 1ml of wash solution and incubated with human Fc-blocking reagent (Miltenyi Biotec, Auburn, CA) for 15 min at 4°C. Monoclonal antibodies (anti-CD161-FITC, CD4-APC-Cy7, CD8-PE-Cy7, or CD3-PE-TexRed) or their respective IgG isotype controls were then added and incubated for 15 min at room temperature in the dark. Then, the cells were washed with 1ml of wash solution and permeabilized with 500μl of 1X permeabilizing solution (BD) for 10 min at room temperature in the dark. The cells were then washed, and monoclonal antibodies (anti-IFN-γ-APC, IL-17A-Alexa700 [Biolegend], IL-4-PE, or TNF-α-PE [BD]) or their corresponding IgG isotype controls were added and incubated for 30 min at room temperature. The cells were washed, and 100,000 events were immediately read using a FACSCanto II flow cytometer (BD). Data analysis was performed using FlowJo research software version OS 10.2 (Tree Star, Inc. Ashland, OR).
+ Open protocol
+ Expand
8

Directed hematopoietic progenitor differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Day 10 hPSC-derived HLF+ HOXA+ hematopoietic progenitors were collected, counted, and seeded in StemPro-34 base media (Thermo Fisher) supplemented with the following factors:

Day 0-5: SCF (50 ng/mL [Peprotech, 300-07]), TPO (10 ng/mL [Peprotech, 300-18]), IL-3 (50 ng/mL [Peprotech, 200-03]), FLT3L (50 ng/mL [Peprotech, 300-19]), M-CSF (50 ng/mL [Peprotech, 300-25]), and ITS-X (Thermo Fisher, 51500-056])

Day 6-10: FLT3L (50 ng/mL), M-CSF (50 ng/mL), GM-CSF (25 ng/mL [Peprotech, 300-03]), and ITS-X

Day 10-17: M-CSF (100 ng/mL), GM-CSF (50 ng/mL), and ITS-X

At day 17, cells were dissociated using TrypLE (Thermo Fisher), stained with CD11b APC antibody (BioLegend, 101212) and CD68 PE Cy7 antibody (Thermo Fisher, 25-0689-42) in the presence of human Fc blocking reagent (Miltenyi Biotec, 130-059-901), and analyzed for flow cytometry.
+ Open protocol
+ Expand
9

Multiparametric Flow Cytometric Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were pre-incubated with 5 μL human Fc Blocking Reagent (Miltenyi Biotech, Bisley, UK) or normal rat serum (in dilution 1:100) for 10 minutes at 4 °C. Aqua Live/Dead™ 405 nm cell stain (Invitrogen, Paisley, UK) or Zombie UV Aqua Fixable Viability Stain (Biolegend, London, UK) was added in dilution 1:200 in PBS and incubated for 5 minutes, followed by the surface antibody cocktail for 30 mins in the dark at 4 °C. All rat (anti-mouse) and mouse (anti-human) antibodies were used in dilution 1:100 and 1:25, respectively. All antibodies used in this study are listed in Supplementary Table 1. Intranuclear Ki-67 staining was performed using eBioscience™ Foxp3/Transcription Factor Staining Buffer Set (ThermoFisher Scientific, Waltham, USA).
Following three washes, samples were measured with BD LSRFortessa using BD FACSDiva 6.2 software (Becton Dickinson, Basel, Switzerland) and data subsequently analysed with FlowJo 10.4 software (TreeStar, USA). Each FACS tube was run until its exhaustion. Cell sorting of murine kidney and bladder MNPs and B cells was done on unfixed cells using Aria-Fusion III (Becton Dickinson, Basel, Switzerland) or iCyt Synergy (Sony Biotechnology Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!